United HealthCare files second amended US antitrust complaint against Celgene over Thalomid, Revlimid
MLex Summary: United HealthCare Services filed its second amended US complaint against Celgene over the company's refusal to provide samples of its Thalomid and Revlimid drugs to generic competitors to use...To view the full article, register now.
Already a subscriber? Click here to view full article